Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.
Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.
复制标题
DOI:
10.1021/acs.jmedchem.9b01035
复制
发表时间:
2019-10
影响因子:
7.3
通讯作者:
Xi Xu;Zijian Kuang;Jie Han;Yingfen Meng;Lei Li;Hongyu Luan;Pengfei Xu;Jubo Wang;C. Luo;H. Ding;Zhiyu Li;Jinlei Bian
中科院分区:
文献类型:
--
作者:
Xi Xu;Zijian Kuang;Jie Han;Yingfen Meng;Lei Li;Hongyu Luan;Pengfei Xu;Jubo Wang;C. Luo;H. Ding;Zhiyu Li;Jinlei Bian
Glutaminase (GLS1) is a cancer energy metabolism protein which plays a predominant role in cell growth and proliferation. Due to its major involvement in malignant tumor, small-molecule GLS1 inhibitors are urgently needed to assess its therapeutic potential and for probing their underlying biology function. Recent studies showed that targeting the allosteric binding site represented a promising strategy for identifying potent and selective GLS1 inhibitors. Herein, we present the synthesis of two fluorescent probes targeting the allosteric binding site of GLS1 and their usage as mechanistic tools in multiple applicable assay platform. The fluorescence polarization (FP)-based binding assay enables easy, fast and reliable screen of allosteric inhibitors from our in-house compound library obtained through click chemistry method. The obtained compound C147 (named as CPU-L1) has been proved to be more potent and with greater solubility than the control compound CB839, which could serve as promising leads for further optimization as novel GLS1 inhibitors.